CW June 2000Issue Number 6 June 2000 ISSN 10593802 Single-Agent Herceptin in Metastatic Breast CancerHerceptin (trastuzumab) is showing promise as a single agent against metastatic breast cancer, especially in patients who are overexpressors of the human epidermal growth factor receptor 2 (HER2) protein.
Go to Previous Page Go to Next Page Source & Additional Reading Reports from ASCO Meeting. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |